A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia who are not Candidates for Intensive Chemotherapy Program: Cusatuzumab
A Study of Cusatuzumab Plus Azacitidine in Japanese Participants with Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome who are not Candidates for Intensive Treatment Program: Cusatuzumab